What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

PUBLISHER: TechSci Research | PRODUCT CODE: 1069641

PUBLISHER: TechSci Research | PRODUCT CODE: 1069641

Global Senolytic Drugs Market, By Type, By Application, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2017-2027

PUBLISHED: April 1, 2022

PAGES: 112 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Description

The global senolytic drugs market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising demands for anti-aging therapeutics and pharmaceuticals. Advances in pharmaceutical drugs and the increasing need for healthy lifespan are accelerating the growth of the global senolytic drugs market. Senescence is a condition or process where cell ages and permanently stop dividing but does not die. In some time, these cells can start accumulating and form a tumor or the development of cancer. The biological process can also result in weaker eyesight, skin wrinkling, lesser hearing capacity, etc. Senolytic drugs are designed to target the senescent cells and destroy them with their effects. Increasing demand for anti-aging drugs and pharmaceutical products to increase the lifespan of human beings are expected to drive the growth of the senolytic drugs market. According to the U.N. Economic and Social Affairs statistics, the number of people aged 65 years and above is expected to grow by 120% and reach around 1.5 billion by 2050. Thus, the increasing geriatric population across the globe is anticipated to propel the growth of the global senolytic drugs market. Moreover, the rising incidences of age-related disorders like cataracts, glaucoma, neurodegenerative diseases, cardiovascular diseases, pulmonary infections, etc., and sedentary lifestyle among the global population are driving the growth of the global senolytic drugs market. The emergence of advanced technologies, from gene therapy to stem cells, and ongoing research activities for innovation in pharmaceutical drugs are anticipated to fuel the growth of the global senolytic drugs market. Accelerating demand for improving and optimizing personalized and preventive care is further driving the growth of the global senolytic drugs market.

The global senolytic drugs market segmentation is based on type, application, distribution channel, regional distribution, and competitive landscape. Based on application, the global senolytic drugs market is divided into longevity, senescence inhibition, cardiovascular diseases, neural degenerative diseases, and others. The longevity segment is expected to dominate the market in the coming years because of the rapidly increasing geriatric population and rising demand for pharmaceutical products aiding the healthy lifespan of humans.

Major players operating in the global senolytic drugs market are AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc., Numeric Biotech, T.A. Sciences, Inc., Recursion Pharmaceuticals, Inc, etc.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F-2027F

Objective of the Study:

To analyze the historical growth in the market size of global senolytic drugs market from 2017 to 2021.
To estimate and forecast the market size of global senolytic drugs market from 2022E to 2027F and growth rate until 2027F.
To classify and forecast global senolytic drugs market based on type, application, distribution channel, region, and competitive landscape.
To identify dominant region or segment in the global senolytic drugs market.
To identify drivers and challenges for global senolytic drugs market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global senolytic drugs market.
To identify and analyze the profile of leading players operating in global senolytic drugs market.
To identify key sustainable strategies adopted by market players in global senolytic drugs market.

Report Scope:

In this report, global senolytic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Senolytic Drugs Market, By Type:

FOXO4-related peptides

bcl-2 Family Inhibitors

Src Tyrosine Kinase Inhibitors

Navitoclax

Dasatinib & Quercetin

Others

Senolytic Drugs Market, By Application:

Longevity

Senescence Inhibition

Cardiovascular Diseases

Neural Degenerative Diseases

Others

Senolytic Drugs Market, By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Senolytic Drugs Market, By Region:

North America

United States
Mexico
Canada

Europe

France
Germany
United Kingdom
Italy
Spain

Asia-Pacific

China
India
Japan
South Korea
Australia

Middle East & Africa

South Africa
Saudi Arabia
UAE

South America

Brazil
Argentina
Colombia

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research was not able to include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global senolytic drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

Senolytic drugs manufacturing companies/partners
Suppliers/Distributers
End-Users
Government bodies such as regulating authorities and policy makers
Organizations, industry associations, forums and alliances related to global senolytic drugs market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc. besides allowing them in strategizing investments and capitalizing on market opportunities.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global senolytic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Senolytic Drugs Market

5. Voice of Customer

5.1. Preference, By Type
5.2. Factors Contributing to Demand for Senolytic Drugs
5.3. Barriers to Adoption of Senolytic Drugs
5.4. Brand Awareness

6. Clinical Trials

6.1. Ongoing Clinical Trials
6.2. Completed Clinical Trials
6.3. Terminated Clinical Trials
6.4. Clinical Trial Analysis

7. Patent Analysis

7.1. Patent Granted (2016-2020)
7.2. Patent Applications Filed

8. Global Senolytic Drugs Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others)
- 8.2.2. By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others)
- 8.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
- 8.2.4. By Company (2021)
- 8.2.5. By Region
8.3. Product Market Map

9. North America Senolytic Drugs Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
9.3. North America: Country Analysis
- 9.3.1. United States Senolytic Drugs Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By Distribution Channel
- 9.3.2. Mexico Senolytic Drugs Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By Distribution Channel
- 9.3.3. Canada Senolytic Drugs Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By Distribution Channel

10. Europe Senolytic Drugs Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
10.3. Europe: Country Analysis
- 10.3.1. France Senolytic Drugs Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By Distribution Channel
- 10.3.2. Germany Senolytic Drugs Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By Distribution Channel
- 10.3.3. United Kingdom Senolytic Drugs Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By Distribution Channel
- 10.3.4. Italy Senolytic Drugs Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Type
    - 10.3.4.2.2. By Application
    - 10.3.4.2.3. By Distribution Channel
- 10.3.5. Spain Senolytic Drugs Market Outlook
  - 10.3.5.1. Market Size & Forecast
    - 10.3.5.1.1. By Value
  - 10.3.5.2. Market Share & Forecast
    - 10.3.5.2.1. By Type
    - 10.3.5.2.2. By Application
    - 10.3.5.2.3. By Distribution Channel

11. Asia-Pacific Senolytic Drugs Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Application
- 11.2.3. By Distribution Channel
- 11.2.4. By Country
11.3. Asia-Pacific: Country Analysis
- 11.3.1. China Senolytic Drugs Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Type
    - 11.3.1.2.2. By Application
    - 11.3.1.2.3. By Distribution Channel
- 11.3.2. India Senolytic Drugs Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Type
    - 11.3.2.2.2. By Application
    - 11.3.2.2.3. By Distribution Channel
- 11.3.3. South Korea Senolytic Drugs Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Type
    - 11.3.3.2.2. By Application
    - 11.3.3.2.3. By Distribution Channel
- 11.3.4. Japan Senolytic Drugs Market Outlook
  - 11.3.4.1. Market Size & Forecast
    - 11.3.4.1.1. By Value
  - 11.3.4.2. Market Share & Forecast
    - 11.3.4.2.1. By Type
    - 11.3.4.2.2. By Application
    - 11.3.4.2.3. By Distribution Channel
- 11.3.5. Australia Senolytic Drugs Market Outlook
  - 11.3.5.1. Market Size & Forecast
    - 11.3.5.1.1. By Value
  - 11.3.5.2. Market Share & Forecast
    - 11.3.5.2.1. By Type
    - 11.3.5.2.2. By Application
    - 11.3.5.2.3. By Distribution Channel

12. South America Senolytic Drugs Market Outlook

12.1. Market Size & Forecast
- 12.1.1. By Value
12.2. Market Share & Forecast
- 12.2.1. By Type
- 12.2.2. By Application
- 12.2.3. By Distribution Channel
- 12.2.4. By Country
12.3. South America: Country Analysis
- 12.3.1. Brazil Senolytic Drugs Market Outlook
  - 12.3.1.1. Market Size & Forecast
    - 12.3.1.1.1. By Value
  - 12.3.1.2. Market Share & Forecast
    - 12.3.1.2.1. By Type
    - 12.3.1.2.2. By Application
    - 12.3.1.2.3. By Distribution Channel
- 12.3.2. Argentina Senolytic Drugs Market Outlook
  - 12.3.2.1. Market Size & Forecast
    - 12.3.2.1.1. By Value
  - 12.3.2.2. Market Share & Forecast
    - 12.3.2.2.1. By Type
    - 12.3.2.2.2. By Application
    - 12.3.2.2.3. By Distribution Channel
- 12.3.3. Colombia Senolytic Drugs Market Outlook
  - 12.3.3.1. Market Size & Forecast
    - 12.3.3.1.1. By Value
  - 12.3.3.2. Market Share & Forecast
    - 12.3.3.2.1. By Type
    - 12.3.3.2.2. By Application
    - 12.3.3.2.3. By Distribution Channel

13. Middle East and Africa Senolytic Drugs Market Outlook

13.1. Market Size & Forecast
- 13.1.1. By Value
13.2. Market Share & Forecast
- 13.2.1. By Type
- 13.2.2. By Application
- 13.2.3. By Distribution Channel
- 13.2.4. By Country
13.3. MEA: Country Analysis
- 13.3.1. South Africa Senolytic Drugs Market Outlook
  - 13.3.1.1. Market Size & Forecast
    - 13.3.1.1.1. By Value
  - 13.3.1.2. Market Share & Forecast
    - 13.3.1.2.1. By Type
    - 13.3.1.2.2. By Application
    - 13.3.1.2.3. By Distribution Channel
- 13.3.2. Saudi Arabia Senolytic Drugs Market Outlook
  - 13.3.2.1. Market Size & Forecast
    - 13.3.2.1.1. By Value
  - 13.3.2.2. Market Share & Forecast
    - 13.3.2.2.1. By Type
    - 13.3.2.2.2. By Application
    - 13.3.2.2.3. By Distribution Channel
- 13.3.3. UAE Senolytic Drugs Market Outlook
  - 13.3.3.1. Market Size & Forecast
    - 13.3.3.1.1. By Value
  - 13.3.3.2. Market Share & Forecast
    - 13.3.3.2.1. By Type
    - 13.3.3.2.2. By Application
    - 13.3.3.2.3. By Distribution Channel